BioCentury
ARTICLE | Clinical News

Acusphere starts Phase II

January 31, 2000 8:00 AM UTC

Acusphere ( Cambridge, Mass.) began a Phase II trial of its AI-700 ultrasound contrast agent for assessing myocardial perfusion in patients with coronary artery disease. ...